The source guide is a literature map, not a product claim The cited papers are used for identity, pathway, marker, model, or analytical context
The most important thing to know is that metformin isnt a quick fix, and it doesnt work the same for everyone
95% medication adherence in the first month 84% of prescribed patients engage with in-app content 56% use Med Tracker (where side effects can also be tracked) 56% engage in meal logging, with an average of 35 meals logged in the first month Patients log weight 1-2 times per week, on average, over the first 8 weeks of treatment Patients use Noom Move workouts an average of 6.9 times in the first month 45% engage with side-effect support in Nooms "Success Kit" Noom appreciates the potential of the new PDURS framework because it provides a way to put a software product on the drug label in an evidence-based way
As maternal asthma is a risk factor for asthma development in offspring, ASHMI was investigated for its use as a preconception maternal treatment to minimize risk to offspring
The Oral route of administration segment is anticipated to be the fastest-growing category with a CAGR of 10.2% from 2026 to 2033, driven by growing patient preference for non-injectable therapies, improving treatment compliance, and ongoing advancements in oral peptide drug delivery technologies